136 related articles for article (PubMed ID: 32681934)
1. Coronary artery disease and the risk-associated LPA variants, rs3798220 and rs10455872, in patients with suspected familial hypercholesterolaemia.
Page MM; Ellis KL; Pang J; Chan DC; Hooper AJ; Bell DA; Burnett JR; Watts GF
Clin Chim Acta; 2020 Nov; 510():211-215. PubMed ID: 32681934
[TBL] [Abstract][Full Text] [Related]
2. Validation and quantification of genetic determinants of lipoprotein-a levels and predictive value for angiographic coronary artery disease.
Anderson JL; Knight S; May HT; Horne BD; Bair TL; Huntinghouse JA; Rollo JS; Muhlestein JB; Carlquist JF
Am J Cardiol; 2013 Sep; 112(6):799-804. PubMed ID: 23735648
[TBL] [Abstract][Full Text] [Related]
3. Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification.
Pechlivanis S; Mahabadi AA; Hoffmann P; Nöthen MM; Broecker-Preuss M; Erbel R; Moebus S; Stang A; Jöckel KH
BMC Med Genet; 2020 Mar; 21(1):62. PubMed ID: 32220223
[TBL] [Abstract][Full Text] [Related]
4. LPA rs10455872 polymorphism is associated with coronary lesions in Brazilian patients submitted to coronary angiography.
Santos PC; Bueno CT; Lemos PA; Krieger JE; Pereira AC
Lipids Health Dis; 2014 Apr; 13():74. PubMed ID: 24776095
[TBL] [Abstract][Full Text] [Related]
5. Investigation of LPA sequence variants rs6415084, rs3798220 with conventional coronary artery disease in Iranian CAD patients.
Rouhani B; Ghaderian SMH; Salehi Z
Hum Antibodies; 2019; 27(2):99-104. PubMed ID: 30594920
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention.
Li ZG; Li G; Zhou YL; Chen ZJ; Yang JQ; Zhang Y; Sun S; Zhong SL
Lipids Health Dis; 2013 Aug; 12():127. PubMed ID: 23978127
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia.
Olmastroni E; Gazzotti M; Averna M; Arca M; Tarugi P; Calandra S; Bertolini S; Catapano AL; Casula M;
J Am Heart Assoc; 2023 May; 12(10):e029223. PubMed ID: 37183858
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
Clarke R; Peden JF; Hopewell JC; Kyriakou T; Goel A; Heath SC; Parish S; Barlera S; Franzosi MG; Rust S; Bennett D; Silveira A; Malarstig A; Green FR; Lathrop M; Gigante B; Leander K; de Faire U; Seedorf U; Hamsten A; Collins R; Watkins H; Farrall M;
N Engl J Med; 2009 Dec; 361(26):2518-28. PubMed ID: 20032323
[TBL] [Abstract][Full Text] [Related]
9. LPA genotype is associated with premature cardiovascular disease in familial hypercholesterolemia.
Paquette M; Bernard S; Thanassoulis G; Baass A
J Clin Lipidol; 2019; 13(4):627-633.e1. PubMed ID: 31103339
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein(a) plasma levels are not associated with incident microvascular complications in type 2 diabetes mellitus.
Singh SS; Rashid M; Lieverse AG; Kronenberg F; Lamina C; Mulder MT; de Rijke YB; Sijbrands EJG; van Hoek M
Diabetologia; 2020 Jun; 63(6):1248-1257. PubMed ID: 32152647
[TBL] [Abstract][Full Text] [Related]
11. Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels.
Lu W; Cheng YC; Chen K; Wang H; Gerhard GS; Still CD; Chu X; Yang R; Parihar A; O'Connell JR; Pollin TI; Angles-Cano E; Quon MJ; Mitchell BD; Shuldiner AR; Fu M
Hum Mol Genet; 2015 Apr; 24(8):2390-400. PubMed ID: 25575512
[TBL] [Abstract][Full Text] [Related]
12. Association of LPA Variants With Aortic Stenosis: A Large-Scale Study Using Diagnostic and Procedural Codes From Electronic Health Records.
Chen HY; Dufresne L; Burr H; Ambikkumar A; Yasui N; Luk K; Ranatunga DK; Whitmer RA; Lathrop M; Engert JC; Thanassoulis G
JAMA Cardiol; 2018 Jan; 3(1):18-23. PubMed ID: 29128868
[TBL] [Abstract][Full Text] [Related]
13. Lack of association of rs3798220 with small apolipoprotein(a) isoforms and high lipoprotein(a) levels in East and Southeast Asians.
Khalifa M; Noureen A; Ertelthalner K; Bandegi AR; Delport R; Firdaus WJ; Geethanjali FS; Luthra K; Makemaharn O; Pang RW; Salem AH; Sasaki J; Schiefenhoevel W; Lingenhel A; Kronenberg F; Utermann G; Schmidt K
Atherosclerosis; 2015 Oct; 242(2):521-8. PubMed ID: 26302166
[TBL] [Abstract][Full Text] [Related]
14. Lack of Association of
Shahid SU; N A S; Humphries S
Dis Markers; 2021; 2021():6692273. PubMed ID: 34194581
[TBL] [Abstract][Full Text] [Related]
15.
Rehberger Likozar A; Blinc A; Trebušak Podkrajšek K; Šebeštjen M
J Cardiovasc Dev Dis; 2021 Dec; 8(12):. PubMed ID: 34940537
[TBL] [Abstract][Full Text] [Related]
16. Use of Lipoprotein(a) to improve diagnosis and management in clinical familial hypercholesterolemia.
Tromp TR; Ibrahim S; Nurmohamed NS; Peter J; Zuurbier L; Defesche JC; Reeskamp LF; Hovingh GK; Stroes ESG
Atherosclerosis; 2023 Jan; 365():27-33. PubMed ID: 36473758
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and influence of LPA gene variants and isoform size on the Lp(a)-lowering effect of pelacarsen.
Karwatowska-Prokopczuk E; Clouet-Foraison N; Xia S; Viney NJ; Witztum JL; Marcovina SM; Tsimikas S
Atherosclerosis; 2021 May; 324():102-108. PubMed ID: 33872986
[TBL] [Abstract][Full Text] [Related]
18. Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.
Zewinger S; Kleber ME; Tragante V; McCubrey RO; Schmidt AF; Direk K; Laufs U; Werner C; Koenig W; Rothenbacher D; Mons U; Breitling LP; Brenner H; Jennings RT; Petrakis I; Triem S; Klug M; Filips A; Blankenberg S; Waldeyer C; Sinning C; Schnabel RB; Lackner KJ; Vlachopoulou E; Nygård O; Svingen GFT; Pedersen ER; Tell GS; Sinisalo J; Nieminen MS; Laaksonen R; Trompet S; Smit RAJ; Sattar N; Jukema JW; Groesdonk HV; Delgado G; Stojakovic T; Pilbrow AP; Cameron VA; Richards AM; Doughty RN; Gong Y; Cooper-DeHoff R; Johnson J; Scholz M; Beutner F; Thiery J; Smith JG; Vilmundarson RO; McPherson R; Stewart AFR; Cresci S; Lenzini PA; Spertus JA; Olivieri O; Girelli D; Martinelli NI; Leiherer A; Saely CH; Drexel H; Mündlein A; Braund PS; Nelson CP; Samani NJ; Kofink D; Hoefer IE; Pasterkamp G; Quyyumi AA; Ko YA; Hartiala JA; Allayee H; Tang WHW; Hazen SL; Eriksson N; Held C; Hagström E; Wallentin L; Åkerblom A; Siegbahn A; Karp I; Labos C; Pilote L; Engert JC; Brophy JM; Thanassoulis G; Bogaty P; Szczeklik W; Kaczor M; Sanak M; Virani SS; Ballantyne CM; Lee VV; Boerwinkle E; Holmes MV; Horne BD; Hingorani A; Asselbergs FW; Patel RS; ; Krämer BK; Scharnagl H; Fliser D; März W; Speer T
Lancet Diabetes Endocrinol; 2017 Jul; 5(7):534-543. PubMed ID: 28566218
[TBL] [Abstract][Full Text] [Related]
19. Cohort profile: role of lipoproteins in cardiovascular disease-the LipidCardio study.
König M; Joshi S; Leistner DM; Landmesser U; Sinning D; Steinhagen-Thiessen E; Demuth I
BMJ Open; 2019 Sep; 9(9):e030097. PubMed ID: 31481563
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein(a) Kringle-IV Type 2 Copy Number Variation Is Associated with Venous Thromboembolism.
Sticchi E; Magi A; Kamstrup PR; Marcucci R; Prisco D; Martinelli I; Mannucci PM; Abbate R; Giusti B
PLoS One; 2016; 11(2):e0149427. PubMed ID: 26900838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
